Changes in fibroblast growth factor 23 levels in normophosphatemic patients with chronic kidney disease stage 3 treated with lanthanum carbonate: results of the PREFECT study, a phase 2a, double blind, randomized, placebo-controlled trial
Crossref DOI link: https://doi.org/10.1186/1471-2369-15-71
Published: 2014-12
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Ureña-Torres, Pablo
Prié, Dominique
Keddad, Karim
Preston, Peter
Wilde, Paul
Wan, Hong
Copley, J Brian
unspecified valid from 2014-05-05
Article History
Received: 15 November 2013
Accepted: 24 April 2014
First Online: 5 May 2014